Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14388
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTadtong S.
dc.contributor.authorWatthanachaiyingcharoen R.
dc.contributor.authorKamkaen N.
dc.date.accessioned2021-04-05T03:34:33Z-
dc.date.available2021-04-05T03:34:33Z-
dc.date.issued2014
dc.identifier.issn1934578X
dc.identifier.other2-s2.0-84894429641
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14388-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84894429641&doi=10.1177%2f1934578x1400900237&partnerID=40&md5=e9a92fb7dca7f0e45bfe3ca3ae6d8fd3
dc.description.abstractFrom the fresh leaf sheathes of lemongrass (Cymbopogon citratus) and rhizomes of galanga (Alpinia galanga) light yellow and colorless oils, respectively, were obtained by hydrodistillation and microwave assisted extraction (MAE) in yields of 0.24% and 0.03%, and 0.11% and trace (w/w), respectively. By GC/MS analysis, five major constituents were identified in lemongrass oil, E-citral, Z-citral, β-myrcene, selina-6-en-4-ol, and cis-ocimene, and five in galanga oil, 1,8-cineole, phenol 4-(2-propenyl)- acetate, dl-limonene, α-pinene, and α-terpineol. Three major components of the combined lemongrass and galanga oils (ratio 7:3, 1:1, 3:7) were 1,8-cineole (46.3%, 31.5%, 19.3%), E-citral (12.8%, 22.7%, 32.8%) and Z-citral (8.5%, 15.2%, 21.6%). The MICs of lemongrass and galanga oils were: against Staphylococcus aureus 0.5% and 4%, v/v, against Pseudomonas aeruginosa 40% and >40%,v/v, against Streptococcus bovis 0.25% and 0.5%, v/v, and against Candida albicans 0.25% and 0.5%, v/v. Citral (from lemongrass oil) gave greater potentiation than 1,8-cineole (from galanga oil). The combination profiles of galanga oil with lemongrass oil (volume ratios 3:7, 1:1, and 7:3) were tested against the four pathogenic microorganisms. Synergistic activity was best noted for only one ratio (volume ratio 3:7) as the Σfic< 1 against all tested microorganisms. The present investigation provides evidenc that the utilization of two essential oils in combination should be assessed for synergistic antimicrobial activity in order to reduce their minimum effective dose.
dc.subjectamoxicillin
dc.subjectantiinfective agent
dc.subjectcineole
dc.subjectcitral
dc.subjectclotrimazole
dc.subjectessential oil
dc.subjectlimonene
dc.subjectmyrcene
dc.subjectocimene
dc.subjectphenol 4 (2 propenyl) acetate
dc.subjectpinene
dc.subjectselina 6 en 4 ol
dc.subjectterpineol
dc.subjectunclassified drug
dc.subjectAlpinia galanga
dc.subjectantimicrobial activity
dc.subjectarticle
dc.subjectbactericidal activity
dc.subjectCandida albicans
dc.subjectcell membrane
dc.subjectCymbopogon citratus
dc.subjectdrug potentiation
dc.subjectextraction
dc.subjecthydrodistillation
dc.subjectinfrared radiation
dc.subjectisolation procedure
dc.subjectleaf sheath
dc.subjectmass fragmentography
dc.subjectmicrobial growth
dc.subjectmicrowave assisted extraction
dc.subjectminimum bactericidal concentration
dc.subjectminimum inhibitory concentration
dc.subjectnonhuman
dc.subjectPseudomonas aeruginosa
dc.subjectrhizome
dc.subjectStaphylococcus aureus
dc.subjectStreptococcus bovis
dc.subjectAlpinia
dc.subjectAnti-Infective Agents
dc.subjectCymbopogon
dc.subjectDrug Synergism
dc.subjectGas Chromatography-Mass Spectrometry
dc.subjectMicrobial Sensitivity Tests
dc.subjectOils, Volatile
dc.titleAntimicrobial constituents and synergism effect of the essential oils from Cymbopogon citratus and Alpinia galanga
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationNatural Product Communications. Vol 9, No.2 (2014), p.277-280
dc.identifier.doi10.1177/1934578x1400900237
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.